Trials / Completed
CompletedNCT01763060
Long Term Follow up of Patients Who Were Treated With Extracorporeal Membrane Oxygenation for Pandemic Influenza A/H1N1 Induced Severe Respiratory Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7 (actual)
- Sponsor
- Karolinska University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- —
Summary
Patients treated with Extracorporeal Membrane Oxygenation (ecmo) for severe respiratory or circulatory failure show severe long term disability due to impaired lung -, cerebral-, cognitive function and impaired quality of life. This study investigates the long term outcome of all patients who are still alive three years after ECMO treatment for severe respiratory failure during the H1N1 2009 pandemic at the Karolinska University Hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | CT scan | |
| BEHAVIORAL | Cognitive function | |
| RADIATION | MRI |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2013-01-08
- Last updated
- 2013-11-21
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01763060. Inclusion in this directory is not an endorsement.